Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-27

Clinical Trial Update: Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial from Novo Nordisk assesses the efficacy of different medication combinations for treating Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Type 2 | Phase 4 | Status: COMPLETED